Big Pharma Seeks to Capitalize on Pain-Reducing Cannabidiol (CBD)

Patients for Medical Cannabis

Maryam Henein

(Image: Lauren Walker / Truthout)(Image: Lauren Walker / Truthout)

Help Truthout keep publishing stories like this one: We depend on reader support! Click here to make a tax-deductible donation today.

The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies, venture capitalists, professional athletes and Big Pharma — not to mention people living with serious, chronic medical conditions. Insiders predict the burgeoning market will be as profitable as the NFL.

Today, if you run a search on PubMed.gov, a medical research database, you’ll find more than 1,500 academic articles on cannabidiol.

View original post 3,013 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s